- World-class certification: SVI Biobank is now ISO 20387 accredited, confirming its compliance with international biobanking standards.
- National leadership: One of only two accredited biobanks in Australia, SVI supports research across cancer, diabetes, and infectious diseases.
- Trusted infrastructure: Operated by NRL, the biobank stores over 50,000 specimens from more than 1,800 participants with secure 24/7 monitoring.
Australia’s St Vincent’s Institute of Medical Research (SVI) Biobank has achieved ISO 20387 accreditation — the global benchmark for biobanking quality. Managed by the National Serology Reference Laboratory (NRL) at Melbourne’s St Vincent’s Hospital, the facility now ensures that every biospecimen it handles meets the highest international standards of traceability and integrity. The certification, granted through Australia’s National Association of Testing Authorities (NATA), makes SVI Biobank one of only two biobanks in Australia to hold ISO 20387 status. Established in 2015 with support from the Helen Macpherson Smith Trust, the repository has grown to hold more than 50,000 specimens from roughly 1,800 participants. Representatives from SVI and NRL say the accreditation will bolster researchers’ confidence in the quality of samples and data supplied for studies worldwide.
ISO 20387: Global Quality Benchmark
ISO 20387:2018 is the international standard that specifies the technical and quality requirements for biobank operations. It covers all aspects of biobanking – including facilities, personnel, processes and equipment – and defines protocols for the collection, preservation, storage, distribution and traceability of biological samples. By aligning with this standard, biobanks around the world can be evaluated under a common framework. The SVI Biobank’s accreditation against ISO 20387 demonstrates its formal competence in biobanking and aligns its practices with the most rigorous international guidelines.
Biobank Services and Research Impact
The SVI Biobank provides an end-to-end service for researchers, offering support from pre-study consultation and planning through to sample collection, processing, storage and data management. The facility can securely store a wide variety of human specimens – such as whole blood, plasma, serum and tissue – for use across any disease area. These resources support projects from basic laboratory research to clinical trials, making the biobank a key enabler of new discoveries. NRL notes that the biobank is equipped to handle an expanding range of specimen types to meet evolving study needs.
Key services offered by SVI Biobank include:
- Pre-study consultation and planning
- Sample collection and processing
- Troubleshooting and adaptation to changing study needs
- Secure, de-identified data collation
- 24/7 temperature-monitored sample storage
Looking Ahead
Looking ahead, the ISO 20387 accreditation positions the SVI Biobank to support more international collaborations and emerging research initiatives. With its formal quality credentials, the facility is expected to attract new studies and maintain rigorous sample management practices. By meeting the ISO standard, the biobank aligns with a global trend toward accreditation – experts note that ISO 20387 is “the most crucial standard in the biobanking regulatory landscape,” essential for increasing confidence, reliability and efficiency of biobanks worldwide. In sum, the SVI Biobank’s new status points to a future where high-quality biospecimens play an even greater role in driving medical research.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and sample/biospecimen management, while connects buyers with top vendors globally.
